Ryuya Shiga

Jan 20, 2025 | ionanalytics.com | Ryuya Shiga |Keane Hoo

Interview SummaryAims to deep-dive into core pharmaceuticals including drug discoveryWill not make unsolicited offers on general principle, Fuji Soft an exceptional caseBain Capital, the Massachusetts-based investment company, is looking to accelerate investments in the life sciences and real estate sectors in Japan this year, Masa Suekane, Partner, Bain Capital told Mergermarket.

Sep 18, 2024 | ionanalytics.com | Manu Rajput |Raiha Mahmoud |Ryuya Shiga |Keane Hoo

Macroeconomic considerations are driving a comeback of Japanese cross-border M&A in 2024. The market is expanding robustly, with both incoming and outbound transactions stepping up the pace. Japan’s outbound M&A in the year to date (10 September; YTD) has seen deal volume spike 36% to USD 44.98bn from the same period last year. By contrast, deal count has fallen to its lowest level since 2010, with only 295 transactions inked.

Jun 26, 2023 | community.ionanalytics.com | Ryuya Shiga

Ahead of our Mergermarket Japan Forum to be held on 29 June, we analyze private equity pipeline activity based on Mergermarket’s Likely to Exit (LTE) predictive algorithm. Mergermarket's LTE predictive analytics assign a score to sponsor-backed companies to help track and predict when an exit could occur through M&A, an IPO, a direct listing or a deSPAC transaction.